| Literature DB >> 26307356 |
Andres Roman-Urrestarazu1, Päivi Lindholm2, Irma Moilanen2, Vesa Kiviniemi3, Jouko Miettunen4,5,6, Erika Jääskeläinen3, Pirjo Mäki4, Tuula Hurtig2,5, Hanna Ebeling2, Jennifer H Barnett1, Juha Nikkinen3,6,7, John Suckling1,8,9, Peter B Jones1,8, Juha Veijola4, Graham K Murray10,11,12.
Abstract
When adolescents with ADHD enter adulthood, some no longer meet disorder diagnostic criteria but it is unknown if biological and cognitive abnorma lities persist. We tested the hypothesis that people diagnosed with ADHD during adolescence present residual brain abnormalities both in brain structure and in working memory brain function. 83 young adults (aged 20-24 years) from the Northern Finland 1986 Birth Cohort were classified as diagnosed with ADHD in adolescence (adolescence ADHD, n = 49) or a control group (n = 34). Only one patient had received medication for ADHD. T1-weighted brain scans were acquired and processed in a voxel-based analysis using permutation-based statistics. A sub-sample of both groups (ADHD, n = 21; controls n = 23) also performed a Sternberg working memory task whilst acquiring fMRI data. Areas of structural difference were used as a region of interest to evaluate the implications that structural abnormalities found in the ADHD group might have on working memory function. There was lower grey matter volume bilaterally in adolescence ADHD participants in the caudate (p < 0.05 FWE corrected across the whole brain) at age 20-24. Working memory was poorer in adolescence ADHD participants, with associated failure to show normal load-dependent caudate activation. Young adults diagnosed with ADHD in adolescence have structural and functional deficits in the caudate associated with abnormal working memory function. These findings are not secondary to stimulant treatment, and emphasise the importance of taking a wider perspective on ADHD outcomes than simply whether or not a particular patient meets diagnostic criteria at any given point in time.Entities:
Keywords: ADHD; Hyperkinetic; MRI; Memory; Neuroanatomy; VBM
Mesh:
Year: 2015 PMID: 26307356 PMCID: PMC4854937 DOI: 10.1007/s00787-015-0755-8
Source DB: PubMed Journal: Eur Child Adolesc Psychiatry ISSN: 1018-8827 Impact factor: 4.785
Fig. 3Upper left panel task design. Participants are shown a set of 3, 4, 5, or 6 letters, followed by a variable delay then a probe letter that may or may not have appeared in the letter set; the task is to indicate whether or not the probe appeared in the letter set or not. Upper right panel adolescence ADHD participants scored significantly lower on the task than control participants (F = 5.59; df = 1.39; p = 0.023); error bars are 95 % confidence intervals. Lower panels mean fMRI percent signal change within the left (lower left panel) and right (lower right panel) caudate ROIs defined in Fig. 1. Error bars are 95 % confidence intervals. The controls show significant trends of increasing activation with increasing memory load bilaterally (p < 0.05); this trend is not present in adolescence ADHD participants (p > 0.5)
Demographic description of the groups for the structural MRI
| Adolescence ADHDa ( | Controls ( | Total ( | ||
|---|---|---|---|---|
| Age | 22.23 (SD 0.7) | 22.95 (SD 0.4) | 22.53 (SD 0.67) | |
| Sex | 37 M:12 F | 17 M:17 F | 54 M:29 F | |
| Handedness | 41 R:8 L | 32 R:2 L | 73 R:10 L | |
| IQ | Mean (std dev) | 96.6 (21.8) | 112.2 (22.6) | 103 (23.1) |
| Education | High school enrolment | 37 (75.5 %) | 8 (23.5 %) | 45 (54.2 %) |
| High school graduation | 12 (24.5 %) | 26 (76.5 %) | 38 (45.7 %) | |
| GAF current | Mean (std dev) | 74.6 (15.5) | 87.26 (4.5) | 79.8 (13.7) |
| Drug use detected by urine sample | Amphetamine and other stimulants | 0 | 0 | 0 |
| Benzodiazepine | 0 | 0 | 0 | |
| Buprenorphine | 0 | 0 | 0 | |
| Cannabis | 5 (10.2 %) | 1 (2.9 %) | 6 (7.2 %) | |
| Cocaine | 0 | 0 | 0 | |
| Opioids | 0 | 0 | 0 | |
aAdolescence diagnosis of ADHD. GAF global assessment of function score
Demographic description of the groups for the fMRI
| Adolescence ADHDa ( | Controls ( | Total ( | ||
|---|---|---|---|---|
| Age | 22.2 (SD 0.7) | 23 (SD 0.4) | 22.6 (SD 0.7) | |
| Sex | 16 M:5 F | 13 M:10 F | 29 M:15 F | |
| Handedness | 18 R:3 L | 22 R:1 L | 40 R:6 L | |
| IQ | Mean (std dev) | 96.4 (19.8) | 111.09 (25.09) | 102.5 (22.6) |
| Education | High school enrolment | 17 (80.9 %) | 5 (21.7 %) | 22 (50 %) |
| High school graduation | 4 (19.1 %) | 18 (78.3 %) | 22 (50 %) | |
| GAF current | Mean (std dev) | 77.1 (11.2) | 87.1 (4.47) | 79.5 (13.8) |
| Drug use detected by urine sample | Amphetamine and other stimulants | 0 | 0 | 0 |
| Benzodiazepine | 0 | 0 | 0 | |
| Buprenorphine | 0 | 0 | 0 | |
| Cannabis | 2 (9.5 %) | 1 (4.3 %) | 3 (6.8 %) | |
| Cocaine | 0 | 0 | 0 | |
| Opioids | 0 | 0 | 0 | |
aAdolescence diagnosis of ADHD. GAF Global Assessment of Function score
Fig. 1Adolescence ADHD individuals exhibit less grey matter volume (GMV) in bilateral caudate nucleus than controls (voxels significantly lower in GMV in the adolescence ADHD group, p < 0.05 family-wise error corrected across the whole brain, are shown in blue). The left side of the image is the right side of the brain in panels a and b. MNI co-ordinates: a y = −10; b z = 22; c x = 16
Fig. 2Plot of combined volume of the two caudate clusters depicted in Fig. 1 that contain voxels of reduced grey matter volume in adolescence ADHD compared to controls. Error bars are 95 % confidence intervals